title: Losigamone.
authors.affiliation: Dr. Willmar Schwabe Arzneimittel, Karlsruhe, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Stein
authors.forename: K
authors.initials: K
authors.lastname: Klessing
authors.forename: S S
authors.initials: SS
authors.lastname: Chatterjee
mesh_terms: D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects; D015507:Drugs, Investigational / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004569:Electroencephalography / Q000187:drug effects; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D005071:Evoked Potentials / Q000187:drug effects; D005663:Furans / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D051381:Rats
chemical_list: D000927:Anticonvulsants; D015507:Drugs, Investigational; D005663:Furans; C065427:losigame